BPSU

The British Paediatric Surveillance Unit is a world leading centre for rare paediatric disease surveillance. It enables doctors and researchers to investigate how many children in the UK and Republic of Ireland are affected by particular rare diseases, conditions or treatments each year. 

Basic page

BPSU study - Juvenile-onset Systemic Lupus Erythematosus

Surveillance of Juvenile-onset Systemic Lupus Erythematosus (JSLE) commenced in September 2017. This study aims to determine the incidence of JSLE in children and young people in the UK and Ireland. The data will be analysed to better understand the epidemiology and clinical features of the disease ...
Committee

BPSU Scientific Committee

The British Paediatric Surveillance Unit Scientific Committee oversees the scientific matters of the BPSU, providing advice and support for researchers wishing to undertake surveillance of rare paediatric disorders through the BPSU 'electronic orange card' reporting scheme.
Committee

BPSU Partnership Board

The officers of the British Paediatric Surveillance Unit are responsible to the Scientific Committee, which in turn is accountable to the BPSU Partnership Board. The Partnership Board was established in 2014 and comprises representation from the three parent bodies of the BPSU, the RCPCH, Department...
Basic page

BPSU study - Congenital Zika syndrome

Surveillance of congenital Zika syndrome in infants under and including six months of age in the UK and Ireland commenced in April 2016. This study aimed to identify all babies with microcephaly or neurological abnormalities born in the UK and Ireland to mothers who have travelled to countries with ...